EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The transcription factor HOXA9 induces expression of the chromatin modifier SMYD3 to drive leukemogenesis

Liping Zhang, Jinqiu Zhong, Luo Yang, Qianyun Ye, Yanli Jin, Chang Liu, Peilong Lai, Hongle Li, Jingxuan Pan, Bei Jin

Journal of Biological Chemistry · 2025

DOI: 10.1016/j.jbc.2025.110320 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2025. Verfasst von Liping Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Bioactive Molecules and Druggability Assessment, Jinan University Institute of Tumor Pharmacology, College of Pharmacy, Jinan…. Hauptthemen laut MEDLINE: Histone-Lysine N-Methyltransferase, Homeodomain Proteins, Leukemia, Myeloid, Acute, Gene Expression Regulation, Leukemic. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Basic and Applied Basic Research Project of Guangzhou Basic Program, the Guangdong Basic and Applied Basic Research Foundation, Basic and Applied Basic Research Foundation of Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fusion oncogene MLL-AF9 initiates AML via downstream targets such as HOXA9. Drivers in the complicated settings of advanced AML, however, remain to be incompletely elucidated. Any factors to incur upregulation of the effector HOXA9 predictably aggravate the effect of DOT1L-mediated H3K79 methylation on HOXA9 expression in MLL-AF9-driven AML. In the present study, we identified that SET and MYND domain-containing protein 3 (SMYD3) was overexpressed in AML and predicted a poor prognosis for patients with AML. Given that H3K4me3 typically activates the transcription of oncogenes, we hypothesized that SMYD3-catalyzed H3K4me3 may directly increase HOXA9 transcription, offering an additional regulation layer to HOXA9 gene transcription activation in MLL-AF9 AML. We tested this hypothesis and unveiled that SMYD3 is responsible for mediating H3K4me3 enrichment and for independently activating HOXA9 transcription. Transcription factor HOXA9 in turn bound to the promoter region of SMYD3 and enhanced its transcription. The resultant vicious circle of SMYD3-H3K4me3-HOXA9 exacerbated proliferation and blocked differentiation in both AML cell lines and primary cells fractionated from patients with AML. Combinational disruption of this loop and DOT1L inhibition led to enhanced anti-leukemia activity against MLL-AF9 AML in vitro and in vivo. In conclusion, our findings may advocate the current understanding regarding the underlying mechanism and offer SMYD3 as a promising intervention target to override the complicated settings in advanced AML.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Histone-Lysine N-MethyltransferaseHomeodomain ProteinsLeukemia, Myeloid, AcuteGene Expression Regulation, LeukemicCarcinogenesisChromatinHumansAnimalsHistonesOncogene Proteins, FusionMiceCell Line, TumorCell ProliferationMyeloid-Lymphoid Leukemia Protein

Stichwörter der Autor:innen

AMLHOXA9MLL-AF9SMYD3differentiationpositive feedback looptranscription activation

Substanzen

homeobox protein HOXA9Histone-Lysine N-MethyltransferaseHomeodomain ProteinsSMYD3 protein, humanHistonesOncogene Proteins, FusionMyeloid-Lymphoid Leukemia ProteinChromatinhistone H3 trimethyl Lys4MLL-AF9 fusion protein, human

Autor:innen und Institutionen

  • State Key Laboratory of Bioactive Molecules and Druggability Assessment, Jinan University Institute of Tumor Pharmacology, College of Pharmacy, Jinan University, Guangzhou, China.
  • State Key Laboratory of Ophthalmology, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Zhongshan Ophthalmic Center; Sun Yat-Sen University, Guangzhou, China.
  • Department of Hematology, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
  • Department of Molecular Pathology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China.
  • State Key Laboratory of Ophthalmology, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Zhongshan Ophthalmic Center; Sun Yat-Sen University, Guangzhou, China. Electronic address: panjx2@mail.sysu…
  • State Key Laboratory of Ophthalmology, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Zhongshan Ophthalmic Center; Sun Yat-Sen University, Guangzhou, China. Electronic address: jinb5@mail.sysu.…

Förderung

  • Basic and Applied Basic Research Project of Guangzhou Basic Program
  • the Guangdong Basic and Applied Basic Research Foundation
  • Basic and Applied Basic Research Foundation of Guangdong Province

Zitieren

APA

Zhang, L., Zhong, J., Yang, L., Ye, Q., Jin, Y., Liu, C., Lai, P., Li, H., Pan, J., & Jin, B. (2025). The transcription factor HOXA9 induces expression of the chromatin modifier SMYD3 to drive leukemogenesis. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2025.110320

Vancouver

Zhang L, Zhong J, Yang L, Ye Q, Jin Y, Liu C, et al. The transcription factor HOXA9 induces expression of the chromatin modifier SMYD3 to drive leukemogenesis. Journal of Biological Chemistry. 2025. doi:10.1016/j.jbc.2025.110320

BibTeX
@article{Zhang2025,
  author = {Zhang, Liping and Zhong, Jinqiu and Yang, Luo and Ye, Qianyun and Jin, Yanli and Liu, Chang and Lai, Peilong and Li, Hongle and Pan, Jingxuan and Jin, Bei},
  title = {The transcription factor HOXA9 induces expression of the chromatin modifier SMYD3 to drive leukemogenesis},
  journal = {Journal of Biological Chemistry},
  year = {2025},
  doi = {10.1016/j.jbc.2025.110320}
}
Kostenlos starten →